Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan · Delayed Price · Currency is TWD 30.50
-0.70 (-2.24%)
May 8, 2026, 12:52 PM CST
Prince Pharmaceutical Market Cap
Prince Pharmaceutical has a market cap or net worth of 1.13 billion as of May 8, 2026. Its market cap has increased by 59.13% in one year.
Market Cap
1.13B
Enterprise Value
1.40B
Revenue
1.06B
Ranking
n/a
PE Ratio
11.86
Stock Price
30.50
Market Cap Chart
Since March 29, 2023, Prince Pharmaceutical's market cap has decreased from 1.94B to 1.13B, a decrease of -41.71%. That is a compound annual growth rate of -15.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.13B | -0.48% |
| Dec 31, 2025 | 1.14B | 42.01% |
| Dec 31, 2024 | 801.65M | -36.72% |
| Dec 29, 2023 | 1.27B | -34.82% |
| Mar 29, 2023 | 1.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TSH Biopharm Corporation | 1.97B |
| Tien Liang BioTech | 1.82B |
| GeneFerm Biotechnology | 1.56B |
| InnoPharmax | 1.54B |
| Winston Medical Supply | 1.26B |
| DV Biomed | 1.17B |
| Excelsior Biopharma | 1.14B |
| Anxo Pharmaceutical | 1.06B |